Parkinsonism from methanol poisoning: Benefit from treatment with anti-Parkinson drugs

被引：0
|
作者：
Davis, LE
Adair, JC
机构：
[1] Vet Affairs Med Ctr, Neurol Serv, Albuquerque, NM 87108 USA
[2] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA
[3] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA
[4] Univ New Mexico, Sch Med, Dept Microbiol, Albuquerque, NM 87131 USA
来源：
MOVEMENT DISORDERS | 1999年 / 14卷 / 03期
关键词：
D O I：
10.1002/1531-8257(199905)14:3<520::AID-MDS1026>3.0.CO;2-V
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：520 / 522
页数：3
相关论文
共 50 条
  • [21] Optimization of Parkinson Disease Treatment Combining Anti-Parkinson Drugs and Deep Brain Stimulation Using Patient Diaries
    Schneider, Jakub
    Novak, Daniel
    Jech, Robert
    2015 37TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2015, : 3444 - 3447
  • [22] Research and development of anti-Parkinson's drugs: an analysis from the perspective of technology flows measured by patent citations
    Qu, Jingwen
    Lu, Jiahong
    Hu, Yuanjia
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2019, 29 (02) : 127 - 135
  • [23] Incidence of use of anti-parkinson drugs among people treated with antipsychotics results from the GIFA study.
    Ferroni, A
    Pedone, C
    Carosella, L
    Gambassi, G
    Bernabei, R
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S28 - S29
  • [24] Anti-Parkinson activity of bioactive substances extracted from Holothuria leucospilota
    Malaiwong, Nawaphat
    Chalorak, Pawanrat
    Jattujan, Prapaporn
    Manohong, Preeyanuch
    Niamnont, Nakorn
    Suphamungmee, Worawit
    Sobhon, Prasert
    Meemon, Krai
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 109 : 1967 - 1977
  • [25] PREVALENCE OF ANTI-PARKINSON DRUGS USE IN FERRARA, NORTHERN ITALY, 1988
    GOVONI, V
    GRANIERI, E
    TOLA, MR
    CASETTA, I
    MONETTI, VC
    FAINARDI, E
    PAOLINO, E
    ACTA NEUROLOGICA SCANDINAVICA, 1994, 89 (06): : 433 - 438
  • [26] Anti-Parkinson drugs consumption. A pharmaco-epidemiological study
    Ponte, M.
    Garcia Merletti, P. F.
    Jurisic, E.
    MOVEMENT DISORDERS, 2009, 24 : S129 - S129
  • [27] REVERSAL OF SOME THERAPEUTIC EFFECTS OF HALOPERIDOL IN SCHIZOPHRENIA BY ANTI-PARKINSON DRUGS
    SINGH, M
    SMITH, JM
    PHARMACOLOGIST, 1971, 13 (02): : 207 - &
  • [28] EVALUATION OF ANTI-PARKINSON DRUGS ON RESERPINE-INDUCED RIGIDITY IN RATS
    GOLDSTEIN, JM
    BARNETT, A
    MALICK, JB
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1975, 33 (01) : 183 - 188
  • [29] Determination of drugs used as anti-Parkinson's disease drugs in urine and serum by capillary electrophoresis
    Vargas, G
    Havel, J
    Babácková, L
    Patocka, J
    JOURNAL OF CAPILLARY ELECTROPHORESIS, 1998, 5 (3-4) : 153 - 158
  • [30] Spending trends on neuropsychiatric drugs in Minas Gerais, Brazil: is the offer of anti-parkinson drugs increasing?
    Silva Carvalho, Liliany Mara
    Alves, Jessica de Castro
    Borges Luz, Tatiana Chama
    CIENCIA & SAUDE COLETIVA, 2021, 26 (08): : 3289 - 3300
12345